RDIF, Panacea Biotec partner to produce Sputnik V in India
First batch produced at Panacea Biotec s facilities at Baddi will be shipped to the Gamaleya Centre for quality control. Full-scale production of the vaccine is due to start soon
BusinessToday.In | May 24, 2021 | Updated 16:22 IST
Sputnik V vaccine got the emergency use authorisation in the country on April 12
Russia s sovereign wealth fund RDIF (Russian Direct Investment Fund) and homegrown pharma company Panacea Biotec have partnered to launch the Russian Sputnik V vaccine in India. The RDIF has already tied up with Dr Reddy s to produce the vaccine in India. Both have agreed to produce 100 million doses per year of Sputnik V.